Milan: Philogen on the rise
(Teleborsa) - The Developer of biopharmaceutical products for the treatment of life-threatening conditions increases its performance, climbing +1.97%.
In the last week Philogen underperformed the FTSE Italia Mid Cap index, therefore showing a lower performance than the benchmark.
The technical scenario for Philogen shows a continuation of the downtrend to test support at 20.7 Euros, with a resistance area at 20.7. The bearish pattern suggests that new lows will probably be tested in the 20.7 area.
These analyses are to be considered solely for information purposes and are not in any way intended to constitute financial advice, a solicitation of funds from the public or the promotion of any form of investment.
(Teleborsa Research Department)
(Teleborsa) 07-10-2024 09:35 AM
In the last week Philogen underperformed the FTSE Italia Mid Cap index, therefore showing a lower performance than the benchmark.
The technical scenario for Philogen shows a continuation of the downtrend to test support at 20.7 Euros, with a resistance area at 20.7. The bearish pattern suggests that new lows will probably be tested in the 20.7 area.
These analyses are to be considered solely for information purposes and are not in any way intended to constitute financial advice, a solicitation of funds from the public or the promotion of any form of investment.
(Teleborsa Research Department)
(Teleborsa) 07-10-2024 09:35 AM